Literature DB >> 26199174

Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.

Patricia Johansson1,2, Anke Bergmann3, Sven Rahmann4, Inken Wohlers4, René Scholtysik2, Martina Przekopowitz2, Marc Seifert2, Gertraud Tschurtschenthaler5, Gerald Webersinke5, Ulrich Jäger6, Reiner Siebert3, Ludger Klein-Hitpass2, Ulrich Dührsen1, Jan Dürig1, Ralf Küppers2.   

Abstract

The pathogenesis of T-cell large granular lymphocytic leukemia (T-LGL) is poorly understood, as STAT3 mutations are the only known frequent genetic lesions. Here, we identified non-synonymous alterations in the TNFAIP3 tumor suppressor gene in 3 of 39 T-LGL. In two cases these were somatic mutations, in one case the somatic origin was likely. A further case harbored a SNP that is a known risk allele for autoimmune diseases and B cell lymphomas. Thus, TNFAIP3 mutations represent recurrent genetic lesions in T-LGL that affect about 8% of cases, likely contributing to deregulated NF-κB activity in this leukemia.
© 2015 UICC.

Entities:  

Keywords:  NF-κB; STAT3; T-LGL; TNFAIP3; tumor suppressor gene

Mesh:

Substances:

Year:  2015        PMID: 26199174     DOI: 10.1002/ijc.29697

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

Review 2.  Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

Authors:  Tal Gazitt; Thomas P Loughran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.

Authors:  Toru Kawakami; Nodoka Sekiguchi; Jun Kobayashi; Taku Yamane; Sayaka Nishina; Hitoshi Sakai; Yukio Hirabayashi; Hideyuki Nakazawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2019-03-11       Impact factor: 2.490

Review 4.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

5.  Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.

Authors:  HeeJin Cheon; Jeffrey C Xing; Katharine B Moosic; Johnson Ung; Vivian W Chan; David S Chung; Mariella F Toro; Omar Elghawy; John S Wang; Cait E Hamele; Ross C Hardison; Thomas L Olson; Su-Fern Tan; David J Feith; Aakrosh Ratan; Thomas P Loughran
Journal:  Blood       Date:  2022-05-19       Impact factor: 25.476

6.  Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.

Authors:  Cédric Pastoret; Fabienne Desmots; Gaëlle Drillet; Simon Le Gallou; Marie-Laure Boulland; Alexia Thannberger; Anne-Violaine Doncker; Véronique Salaun; Gandhi Laurent Damaj; Richard Veyrat-Masson; Olivier Tournilhac; Aline Moignet; Céline Pangault; Mikaël Roussel; Thierry Fest; Thierry Lamy
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

7.  STAT3 and STAT5B mutations have unique distribution in T-cell large granular lymphocyte proliferations and advanced myeloid neoplasms.

Authors:  Shiqiang Qu; Yujiao Jia; Huijun Wang; Xiaofei Ai; Zefeng Xu; Tiejun Qin; Lijuan Pan; Bing Li; Gang Huang; Robert Peter Gale; Zhijian Xiao
Journal:  Leuk Lymphoma       Date:  2021-01-07

8.  Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach.

Authors:  A Coppe; E I Andersson; A Binatti; V R Gasparini; S Bortoluzzi; M Clemente; M Herling; J Maciejewski; S Mustjoki; S Bortoluzzi
Journal:  Leukemia       Date:  2017-02-07       Impact factor: 11.528

9.  miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20.

Authors:  Zixing Liu; Kelly R Smith; Hung T Khong; Jingshan Huang; Eun-Young Erin Ahn; Ming Zhou; Ming Tan
Journal:  Oncotarget       Date:  2016-11-29

10.  A guilt-by-association mutation network in LGL leukemia.

Authors:  Emma I Andersson; Alessandro Coppe; Stefania Bortoluzzi
Journal:  Oncotarget       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.